(1R,3R)-Cyclopentane-1,3-diamine dihydrochloride

Catalog No. :
ACGFPX913
CAS No. :
1820579-91-6
Molecular Formula :
C5H14Cl2N2
Molecular Weight :
173.09

IUPAC Name:(1R,3R)-cyclopentane-1,3-diamine dihydrochloride

(1R,3R)-Cyclopentane-1,3-diamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$337.00Login to see priceIn stockInquiry
250mg95%$536.00Login to see priceIn stockInquiry
500mg95%$895.00Login to see priceIn stockInquiry
1g95%$1340.00Login to see priceIn stockInquiry
5g95%$4020.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1R,3R)-Cyclopentane-1,3-diamine dihydrochloride
IUPAC Name(1R,3R)-cyclopentane-1,3-diamine dihydrochloride
MDL No.MFCD29925586
Molecular FormulaC5H14Cl2N2
Molecular Weight173.09
SMILESN[C@H]1C[C@H](N)CC1.[H]Cl.[H]Cl
InChI KeyUQEZIVFRVHUPSU-ALUAXPQUSA-N
Synonymtrans-Cyclopentane-1,3-diamine dihydrochloride | 1799439-22-7 | (1R,3R)-cyclopentane-1,3-diamine | dihydrochloride | 1820579-91-6 | MFCD27952970 | AKOS022186687 | CS-W007211 | DS-8499 | (1R,3R)-Cyclopentane-1,3-diamine diHCl | trans-Cyclopentane-1,3-diami
CAS No.1820579-91-6
PubChem CID73554511

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACGFPX913 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGYLB375 route compound structure diagram
    ACGYLB3751956310-58-9 In Stock
  2. Then
  3. ACGFPX913 route product structure diagram
    ACGFPX9131820579-91-6 In Stock
Inquiry

2. ACGFPX913 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGFPX913 route product structure diagram
    ACGFPX9131820579-91-6 In Stock
Inquiry

Comments (0)